Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that.
Posting a small dataset on Hypertension improvement. It is mine, it is uncontrolled, and the method is stated so it can be discounted appropriately.
What I would like is not agreement but a second dataset collected by someone with no stake in mine. If one exists I would rather read it than argue for this one.
The arithmetic in the opening post is right; the assumption feeding it is the part to check.
My experience of Hypertension improvement contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
What I would want before treating Hypertension improvement as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
Building on post #4 rather than restating it.
Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
I would want to see it done twice before believing it once.
I would put moderate confidence on the mainstream reading of Hypertension improvement and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.
Taking post #8 at face value and following it one step further.
Eating-disorder history is raised here regularly and is the case where the guidance most consistently says the decision needs specialist input.
The uncertainty is in the assumption, not in the calculation.
That is consistent with mine, for whatever one more account is worth.
Post #9 put the caveat in the right place and I want to underline it.
A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history.
Reframing Hypertension improvement slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows.
Adding what did not work for me on Hypertension improvement, since the failures never get written up and they are half the useful information.
The arithmetic in post #13 is right; the assumption feeding it is the part to check.
Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.
It is the kind of thing that is obvious once and never again.
The bit of Hypertension improvement that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.
Narrowing post #17, because the general version has more than one answer.
I have three months of notes on Hypertension improvement and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion from the first fortnight.
Where the Hypertension improvement discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.
This follows post #17 rather than contradicting it.
Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
This is the sort of thing the wiki should carry and currently does not.
Post #18 is the version of this I will quote in future. One addition.
Summarising the Hypertension improvement thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.
Since Hypertension improvement keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.
Nothing to add, except that this is the answer I would give if asked.
A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied.
I would call the community position on Hypertension improvement likely rather than established, and I would be comfortable defending that hedge.
Answering the question post #25 raises rather than the one it answers.
Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not independent variables.
Nothing above should be read as advice about what anyone else should do.
A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history.